Company / Operating Income per Share
AXIM BIOTECHNOLOGIES, INC. Operating Income per Share History
FY2015-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$0.01
FY2023
5-year range
-$0.09 / -$0.01
FY2019-FY2023
Trend
+57.6%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $-0.09 to $-0.01 over the past 5 years.
Based on SEC 10-K filings.
-0.01 in FY2023.
Improved from $-0.09 to $-0.01 over the past 5 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2023, operating income per share increased 57.6% year-over-year.
- Lowest operating income per share in the period was in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -18.18 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | -$0.01 | +57.6% |
| FY2022 | -$0.03 | +63.5% |
| FY2018 | -$0.09 | -53.9% |
| FY2017 | -$0.06 | +36.8% |
| FY2016 | -$0.09 | +68.9% |
| FY2015 | -$0.30 | - |
| FY2013 | - | - |
| FY2012 | - | - |
| FY2011 | - | - |
As of FY2023 · SEC 10-K · Updated Jun 29, 2026